As of 2026-03-26, the Relative Valuation of Harpoon Therapeutics Inc (HARP) is (29.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.01 USD, the upside of Harpoon Therapeutics Inc based on Relative Valuation is -226.4%.
The range of the Relative Valuation is (26.57) - (30.73) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.6x - 22.9x | 20.2x |
| Forward P/E multiples | 17.8x - 21.6x | 20.6x |
| Fair Price | (26.57) - (30.73) | (29.07) |
| Upside | -215.5% - -233.5% | -226.4% |
| Date | P/E |